Novartis Leqvio (inclisiran) analyses show effective and sustained LDL-C reduction in two sub-populations of patients with ASCVD Read more
European Commission Approves BioMarin’s VOXZOGO (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close Read more
Forxiga approved in Japan for the treatment of chronic kidney disease in patients with and without type-2 diabetes Read more
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 Read more
Pardes Biosciences Initiates First-in-Human Trial for PBI-0451, an Oral Antiviral in Development to Treat and Prevent SARS-CoV-2 Infections Read more
GW Pharmaceuticals, Zelira Therapeutics and Roche Gather for In-Person Cannabinoid Derived Therapeutics Summit Read more
Eagle Pharmaceuticals Announces Worldwide Licensing Agreement with Combioxin SA for Phase 2b/3, Novel First-in-Class Antitoxin Agent CAL02 in Development for Combination Use with Antibiotics for the Treatment of Severe Pneumonia Read more
Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders Read more